Improving adverse drug reaction reporting through workshops and telephone education in Portugal

Completed

• Conditions: nder-reporting adverse drug reactions; Injury, Occupational Diseases, Poisoning; Complication of surgical and medical care, unspecified

• Registration Number: ISRCTN33698297
• Lead Sponsor: orthern Pharmacosurveillance Unit (Portugal)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2011-09-13
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 6579

Inclusion Criteria

All National Health System physicians working in the northern region of Portugal

Exclusion Criteria

1. Physicians not involved in any clinical activity (e.g. engaged in administrative tasks, analysis, etc.)
2. Working in substance abuse and rehabilitation centres
3. Working at the regional pharmacosurveillance centre or any department having a specific voluntary adverse drug reaction reporting program and physicians attached to specific hospitals (cancer, maternity, etc)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Rate of total notifications per month

Secondary Outcome Measures

Name	Time	Method
Rate of serious, unexpected, high-causality and new-drug-related adverse drug reactions per month